|
|
|
- 您 可 以 信 任 的 醫 學 圖 書 智 庫 |
|
The Sanford Guide to Antimicrobial Therapy 2016
The Sanford Guide to Antimicrobial Therapy 2016
-感染科
- 編號： 0-0----00000001122354
- 作者：The Sanford Guide
- 原價-1500 - (熱賣價)950 - 節省 ↓37%
- 加入購物車
推薦指數：
- 內容介紹
The Sanford Guide to Antimicrobial Therapy
Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians, the Sanford Guide to Antimicrobial Therapy provides information that is convenient, concise, and reliable. The "gold standard" for infectious diseases since 1969, the Sanford Guide to Antimicrobial Therapy's recommendations are evidence-based and extensively referenced. Updated each year, the 2016 edition includes many significant changes.
Available in 3 sizes and bindings, with additional accessories available. Print editions are updated annually, with the 2016 edition slated for release in April. Pre-order yours today at the Sanford Guide Online Store.
Coverage includes:
•Clinical syndromes
•pathogens
•bacterial
•fungal
•mycobacterial
•parasitic
•viral
•Anti-infective agents
•dosing
•pediatric adjustments
•renal adjustments
•adverse affects
•activity
•pharmacology
•interactions
•Preventative therapy
Areas of significant change in this 46th edition include:
•Initial Approach to Antimicrobial Therapy: Significant updates to genital tract infections based on new CDC STD Guidelines, empiric therapy for pneumonia, and updated regimens and references.
•Spectra of Activity: Completely reworked table with more descriptive classification system, printed in color for improved ease of use.
•Drug Desensitization: Desensitization methods for additional drugs have been added.
•Antimicrobial Use During Lactation: New table on the safety of antimicrobials in lactating mothers.
•HCV: New direct-acting agents and combination agents, along with updated HCV treatment regimens.
•Pediatric Dosing: New table summarizing dosing of antimicrobials in children age 28 days or older.
•Renal Impairment Adjustments: Table has been thoroughly reworked to improve easy of use.
•New Drugs: ceftazidime-avibactam, ceftolozane-tazobactam, isavuconazole.
|
|
|
|
|
└ 返回上一頁
|
|
